Epigenetic regulation of fatty acid amide hydrolase in Alzheimer disease.
<h4>Objective</h4>Alzheimer disease (AD) is a progressive, degenerative and irreversible neurological disorder with few therapies available. In search for new potential targets, increasing evidence suggests a role for the endocannabinoid system (ECS) in the regulation of neurodegenerativ...
Guardado en:
Autores principales: | Claudio D'Addario, Andrea Di Francesco, Beatrice Arosio, Cristina Gussago, Bernardo Dell'Osso, Monica Bari, Daniela Galimberti, Elio Scarpini, A Carlo Altamura, Daniela Mari, Mauro Maccarrone |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2012
|
Materias: | |
Acceso en línea: | https://doaj.org/article/356f64993bd64394bf1b45b7d3c01d4d |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Pharmacological and Epigenetic Regulators of NLRP3 Inflammasome Activation in Alzheimer’s Disease
por: Francesca La Rosa, et al.
Publicado: (2021) -
Ten-year outcome of vagus nerve stimulation-implanted patients with treatment-resistant depression: two Italian cases
por: Dell'Osso B, et al.
Publicado: (2018) -
Dysfunction in fatty acid amide hydrolase is associated with depressive-like behavior in Wistar Kyoto rats.
por: K Yaragudri Vinod, et al.
Publicado: (2012) -
The Inhibition of the Degrading Enzyme Fatty Acid Amide Hydrolase Alters the Activity of the Cone System in the Vervet Monkey Retina
por: Joseph Bouskila, et al.
Publicado: (2021) -
Genetic Variants of Fatty Acid Amide Hydrolase Modulate Acute Inflammatory Responses to Colitis in Adult Male Mice
por: Haley A. Vecchiarelli, et al.
Publicado: (2021)